256 results

Posted on 14.03.2024

Building resilient healthcare systems in Europe

MedTech Europe Manifesto: The EU has a key role in preparing for future challenges, from AMR and climate to global trade distortions and supply chain disruption  European health systems have faced severe stress tests in recent years, revealing some of the strengths and weaknesses of our services and institutions. Learning from this experience will be […]

By Oliver Bisazza Chief Executive Officer, MedTech Europe

Access Cancer

Posted on 18.10.2023

Increasing Education of Breast Reconstruction for Breast Cancer Survivors

Every year during Breast Cancer Awareness Month, Breast Reconstruction Awareness Day aims to educate, engage, and empower women who have been diagnosed with breast cancer to know their breast reconstruction options, and to be confident in having an informed discussion with their care team about what’s best for them. While breast reconstruction may not be […]

By Alex Holmes Mentor EMEA Lead, J&J MedTech

Getting checked

Posted on 07.09.2023

The value of timely interventions in emergency care: IVDs laying the groundwork for urgent care success

As we have learned over the last few years, we cannot postpone reforms to our public health systems if we want to combat and prepare for future pandemics. As someone who has worked in the in-vitro diagnostic (IVD) industry for more than 25 years, I believe in the importance of setting high-quality standards for IVD […]

By Daniel White Vice President Europe, Cepheid

Posted on 27.04.2023

Join us in Dublin for The MedTech Forum 2023

More than 1,500 industry leaders will discuss the biggest issues facing our sector The countdown has begun. At the end of May, leading thinkers and decision-makers from across the medical technology sector will descend on the Irish capital city for Europe’s leading medtech industry event from 30 May to 1 June. Organised by MedTech Europe, […]

Business

Posted on 22.03.2023

Can IVD market sustain stellar growth?

Europe’s in vitro diagnostics (IVD) market has expanded sharply since 2020, with demand for SARS-CoV-2 tests driving double-digit growth for the past two years. In 2020, total revenues for the IVD sector rose by 29.1%That striking growth rate was eclipsed by 2021’s unprecedented growth of 43.7%.

By Teodora Angelova Senior Manager Market Data

Digital

Posted on 28.10.2022

Advancing health data with a purpose

Digitalisation has great potential to help improve healthcare provision and patient outcomes. This innovative transformation is being addressed both at the practical and policy level. I believe that the success of such transformation is hidden in approaching health data as a means toward a holistic solution, rather than a goal on its own. Over the […]

By Nick Guldemond CEO and Founder

Business

Posted on 05.10.2022

Thinking of joining an EU project? Read our top tips

The new Innovative Health Initiative (IHI) has prompted companies in the medical technology industry to think about taking part in more EU projects. For some, this is a new opportunity to build on existing experience. For others, it’s a new venture. With the right preparation, there are real benefits on offer thanks to this exciting […]

By Patrick Boisseau Director Research and Innovation, MedTech Europe

Digital Regulation

Posted on 15.09.2022

Should the EU rewrite the rulebook on liability in response to advances in artificial intelligence?

As lawyers we tend to use academic journals to tease out complex legal questions. (See our latest contribution to the literature here). However, today we’re taking the opportunity to discuss a hot topic with a broader audience, as we feel it will have a profound impact on the public, patients and health systems. That topic […]

By Ulrich Juknat Legal Director Regulatory Law

Value

Posted on 14.07.2022

Addressing new expectations for the future of health

The past few years have seen a seismic shift in the entire healthcare landscape. The COVID-19 crisis required a new level of “always-on” and “right now” innovation to enable care to be delivered to the front lines, to all patients, and across geographies. As COVID-19 evolves from an acute crisis to a chronic issue with unpredictable ebbs and flows, the hyper-focused approach to innovation is more important than ever. The world now knows what we can do, even when conditions are less than optimal. Our focus on helping patients by getting the best evidence, tools, and support to clinicians demonstrated the power of collaboration, imagination and dedication. Moving forward, patients and healthcare partners will accept nothing less than that level of commitment to transform the future of health forever.

By Ashley McEvoy Executive Vice President, Worldwide Chair, Johnson & Johnson MedTech